FdaApplication
ANDA 212630
Identifiers
- fda_app_no: ANDA212630
Properties
| Property | Value |
|---|---|
| applicant_name | CHARTWELL RX |
| application_type | ANDA |
| approval_date | 2021-11-29 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CHLORPROMAZINE HYDROCHLORIDE | CHLORPROMAZINE HYDROCHLORIDE | 200MG | TABLET;ORAL |
| CHLORPROMAZINE HYDROCHLORIDE | CHLORPROMAZINE HYDROCHLORIDE | 50MG | TABLET;ORAL |
| CHLORPROMAZINE HYDROCHLORIDE | CHLORPROMAZINE HYDROCHLORIDE | 10MG | TABLET;ORAL |
| CHLORPROMAZINE HYDROCHLORIDE | CHLORPROMAZINE HYDROCHLORIDE | 25MG | TABLET;ORAL |
| CHLORPROMAZINE HYDROCHLORIDE | CHLORPROMAZINE HYDROCHLORIDE | 100MG | TABLET;ORAL |
5 products